United States Multiple Sclerosis Market and Competitive Landscape Highlights 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Multiple Sclerosis Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Multiple Sclerosis Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Multiple Sclerosis pipeline products, Multiple Sclerosis epidemiology, Multiple Sclerosis market valuations and forecast, Multiple Sclerosis products sales and competitive landscape in the US.

The research is classified into nine sections - Multiple Sclerosis overview including etiology, pathophysiology, and diagnosis, Multiple Sclerosis treatment options, Multiple Sclerosis pipeline products, Multiple Sclerosis market analysis comprising of Multiple Sclerosis epidemiology, key products marketed for Multiple Sclerosis, market valuations and forecast, products sales and market shares.

Research Scope:

  • Multiple Sclerosis Pipeline: Find out the products in clinical trials for the treatment of Multiple Sclerosis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Multiple Sclerosis Epidemiology: Find out the number of patients diagnosed (prevalence) with Multiple Sclerosis in the US
  • Multiple Sclerosis Products: Identify key products marketed and prescribed for Multiple Sclerosis in the US, including trade name, molecule name, and company
  • Multiple Sclerosis Product Sales: Find out the sales revenues of Multiple Sclerosis products, both branded and generics, in the US
  • Multiple Sclerosis Market Valuations: Find out the market size for Multiple Sclerosis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Multiple Sclerosis Products Market Share: Find out the market shares for key Multiple Sclerosis products in the US

Key Topics Covered:

  1. Disease Overview
  2. Multiple Sclerosis Treatments
  3. Multiple Sclerosis Pipeline
  4. US Multiple Sclerosis Epidemiology
  5. Marketed Drugs for Multiple Sclerosis in US
  6. US Multiple Sclerosis Market Size
  7. US Multiple Sclerosis Products Sales
  8. US Multiple Sclerosis Market Competitive Landscape
  9. US Multiple Sclerosis Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/x33lcn/us_multiple

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Central Nervous System Drugs